ACRV · Acrivon Therapeutics, Inc.
Market Cap
$88.28M
Shares
42.85M
Acrivon Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Acrivon Therapeutics, Inc. (ACRV), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Earnings call
FY26 · Q1
2026-05-26
Acrivon Therapeutics, Inc. (ACRV) Q1 2026 Earnings Call
Diluted EPS
$-0.49
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-01-08
Acrivon Therapeutics, Inc. (ACRV) Q4 2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q4
2025-03-25
Acrivon Therapeutics, Inc. (ACRV) Q4 2024 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q2
2024-08-13
Acrivon Therapeutics, Inc. (ACRV) Q2 2024 Earnings Call
Diluted EPS
$-0.52
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-04-24
Acrivon Therapeutics, Inc. (ACRV) Q4 2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q1
2024-04-24
Acrivon Therapeutics, Inc. (ACRV) Q1 2024 Earnings Call
Diluted EPS
$-0.73
Audio
Transcript
Slides
8-K10-Q
Showing 1–6 of 6 earnings calls
Key facts
CIK
1781174
CUSIP
004890109
13F (30d)
44 filings
44 filers
Visit website
Investor relations